abstract |
Aspects of the present invention relate to pro-drug forms of chemotherapeutic compounds, which forms selectively target cancerous cells, thereby reducing the discomfort and deleterious side effects associated with systemic administration of the chemotherapeutic compounds. The present invention also relates to use of said pro-drug forms in the treatment of hyperproliferative diseases, cancers, and the like. |